Topic Listing for Akzo Nobel N.V.

Accounting Pensions Other Postretirement Benefits Accounting Stock Issued Employees
Acquisitions Dispositions Activities 2004
Adverse Stock Market Developments Affect Assets Pension Funds Age-limit Requirements
Akzo Nobel Akzo Nobel Announces Intended Sale Organon Biosciences Schering-plough
Akzo Nobel Coatings Chemicals Akzo Nobel Consolidated Statements Income
Akzo Nobel Listed Dow Jones Sustainability Indexes Akzo Nobel Listed Ftse4good Index
Akzo Nobel Offer Update Takeover Panel Extension Akzo Nobel Top Performer Social Responsibility Index
Amendment Articles Association Antitakeover Provisions Control
Antitrust Cases Appointment Conflicts Interest
Arnhem Netherlands 2007 Akzo Nobel Announced Today Decided Arnhem Netherlands 2007 Akzo Nobel Confirms Approached Board
Arnhem Netherlands 2007 Akzo Nobel Confirms Further Indicative Arnhem Netherlands 2007 Akzo Nobel Euronext Amsterdam Akz
Articles Association Akzo Nobel 2005 English Translation Asset Retirement Obligations
Assets Liabilities Classified Held Sale Assets Liabilities Held Sale Organon Biosciences
Associated Companies Joint Ventures Attestation Report Registered Public Accounting Firm
Audit Committee Audit Committee Financial Expert
Autonomous Growth Back Contents
Bad Publicity Damage Brands Adversely Affect Business Results Base Chemicals
Base Salary Base Salary 2004
Base Salary 2006 Bases Sources Information
Because Conducts International Operations Exposed Variety Risks Them Because Organon Depends Sale Limited Number Products Generate
Binding Cash Offer Organon Biosciences Schering-plough Board Management
Board Practices Business Combinations
Business Continue Expose Risks Environmental Liabilities Business Overview
Business Review Business Review Developments Units
Business Units Capital Expenditures
Capital Gains Capital Reduction
Capital Stock Car Refinishes
Cases Cash Equivalents
Cash Flows Certain Trading Activities
Certification Ceo Certification Ceo 906
Certification Cfo Certification Cfo 906
Changes Accounting Principles Due Adoption Ifrs Changes Board Management
Changes Consolidated Interests Changes Supervisory Board
Chemicals Chemicals Group
Chemicals New Growth Strategy Paying Off Strong Start Coatings
Coatings Chemicals Coatings Excellent Growth Significantly Improved Ebit Margin
Coatings Group Code Ethics
Collaborations Licensing Agreements Commitments
Commitments Values Committees
Commodities Commoditiy Price Risk Management
Community Program Compared 2002
Compared 2003 Compensation Remuneration 2006
Conflict Interest Consent Independent Auditor
Consolidated Statements Other Financial Information Consolidation
Contractual Obligations Controls Procedures
Corporate Governance Corporate Social Responsibility
Costs Expenses Costs Sales
Court Case Netherlands Pensions Court Cases
Credit Risk Credit Risk Management
Critical Accounting Policies Cumulative Translation Differences
Current Liabilities Current Taxes
Dealing Disclosure Requirements Decorative Coatings
Decorative Coatings Europe Decorative Coatings International
Deferred Income Deferred Tax Provisions
Deferred Taxes Defined Benefit Plans
Derivative Financial Instruments Description Chemicals Business
Description Coatings Business Description Pharmas Business
Details Irrevocable Undertakings Developments Coatings Business Units
Diosynth Diosynth Complex Active Pharmaceutical Ingredients
Directors Senior Management Discharge Indemnification Members Board Management Supervisory
Disclosure Controls Procedures Disclosure Table Giving Details Companies Whose Relevant Securities
Discounting Divestment Unit
Dividend Eur 120 Per Common Share Proposed Dividend Policy
Dividend Proposal Dividends
Documents Display Downgrading Credit Rating Agencies Result Higher Financing Costs
Earnings Nonconsolidated Companies Earnings Per Share
Ebit Ebit Margin
Ebit Operating Income Before Incidentals Ebitda
Editors Effective Strategy Drives Revenues Growth Net Income
Emission Rights Employee Benefits
Employee Share Plan Employees
Employment Agreements Energy
Engineering Environmental Matters
Estate Gift Taxes Estimates
Eur Share Buyback Program Exchange Controls
Exchange Rate Fluctuations Harmful Impact Financial Results Exchange Rates Key Currencies
Exemptions Listing Standards Audit Committees Exhibits
Expenses Explanation Transition Ifrs
Explanatory Remarks Face Intense Competition New Products Lower-cost Generic
Failure Complete Sale Organon Biosciences Obs Result Certain Failure Manage Expansion Effectively Adversely Affect Business
Fair Value Financial Instruments Financial Condition Results Operations Adversely Affected Not Successfully
Financial Information Financial Information Consolidated Statements Other
Financial Instruments Financial Noncurrent Assets
Financing Charges Financing Charges Net
Financing Income Expenses Financing Objectives
Foreign Currency Exchange Risk Management Foreign Exchange Risk Management
Form 20-f Forward Exchange Contracts
Forward Looking Statement 2005 Forward Looking Statement 2006
Forward Looking Statement 2007 Functional Chemicals
Further Proposal Akzo Nobel Rejected Ici Gaap
Gains Divestments General
General Meeting Shareholders General Meeting Shareholders 2004
Geographic Developments Government Grants
Government Regulation Guarantees
Headcount Expansion Emerging Markets Restructuring Mature Held Maturity Investments
History Development Human Resources
Ias Fair Value Adjustments Ifrs
Ifrs Impact 8211 Net Income Shareholders Equity Down Ifrs Impact Net Income Shareholders Equity Down Funds
Ifrs Standards Prospective Impact Illustrative Combined Condensed Financial Information Introduction
Impairment Intangible Assets Property Plant Equipment Impairments
Implementation International Financial Reporting Standards Inability Access Raw Materials Growth Cost Expenses Petroleum
Incidentals Incidentals Balance Gain Eur
Incidentals Net Gain Eur 221 Income Tax Receivable Payable
Income Taxes Indemnification Members Board Management Supervisory
Index Inducement Fee
Industrial Activities Industrial Finishes
Industry Segment Information Industry Segment Information Geographic Data
Information Financial Instruments Insurance
Intangible Assets Intellectual Property
Inter Alia Interest Rate Derivatives
Interest Rate Risk Management Interest Risk Management
Interim Dividend Unchanged Eur 030 Internal Control Integrated Framework
Internal Control-integrated Framework Internal Risks
Intervet Intervet Solid Performance
Intervet Veterinary Products Introduction
Inventories Inventory Costs Amendment Arb Chapter
Invested Capital Investment Associates
Jointly Controlled Companies Key Figures
Leases Legal Antitrust Environmental Cases
Legal Proceedings Liquidation Rights
Liquidity Capital Resources Long-term Borrowings
Long-term Borrowings Short-term Debt Long-term Incentives
Long-term Incentives 2006 Lower Cash Position Due Share Buyback Program
Major Shareholders Major Shareholders Related Party Transactions
Management Change Not Adequate Possibly Lead Failure Attract Managements Annual Report Internal Control Over Financial Reporting
Marine Protective Coatings Marketing Distribution
Markets Material Contracts
Memorandum Articles Association Movements
Moving Average Roi Nature Forward-looking Statements Involve Risk Uncertainty Because They
Net Financing Charges Net Income
Net Income Down Net Income Lower Major Influence One-off
Net Interest-bearing Borrowings Netherlands Taxation
New Accounting Pronouncements New Pension Scheme Netherlands
New Strategic Focus Nobilas
Nobilas Accident Management Services Been Transferred Coatings Other Nobilas Claims Fleet Solutions
Nobilon Nomination Committee
Nonconsolidated Companies Nonconsolidated Flexsys
Nonrecurring Not Able Identify Future Acquisitions Successful Integrating Acquired
Not Able Identify Significant Technology Improvements Future Acquisitions Not Publication Information
Notes Number Employees
Nurturing Talent Off-balance Sheet Transactions
Offer Listing Offer Listing Details
Offer Period Otherwise Ends Persons Act Together Pursuant One-off
Operating Income Operational Cash Flow Lower Due Higher Working Capital
Operational Income Operational Performance
Organizational Structure Organon
Organon Biosciences Organon Figures Now Also Include Results Former Diosynth
Organon Intervet Organon Prescription Drugs
Other Other Adjustments
Other Employee Benefits Other Financial Noncurrent Assets
Other Financial Noncurrent Assets Available Sale Other Investigations Litigation
Other Litigation Other Long-term Employee Benefits
Other Operating Income Other Operating Income Expenses
Other Principles Observed Preparation Statement Income Other Provisions
Other Results Outcome Tax Disputes Litigation Indemnification Guarantees Regulatory Action
Outlook Outlook Unchanged
Overview Part
Pensions Pensions Other Postretirement Benefits
Percent Total Net Sales Operating Income Percent Total Revenues Operating Income
Performance Development Dialog Performance Share Plan Board Management
Pfizer Payment Pharma
Pharma Group Planet
Polymer Chemicals Powder Coatings
Preemptive Rights Present Operations Exclude Chemicals Businesses Divested 2004 Incidentals
Presentation Ifrs-based Information Price Controls
Principal Accountant Fee Services Principal Objects
Principles Principles Determination Income
Principles Valuation Assets Liabilities Product Liability Claims Adversely Affect Business Results Operations
Product Regulation Adversely Affect Ability Bring New Products Property Plant Equipment
Provisions Provisions Environmental Costs
Provisions Restructuring Activities Pulp Paper Chemicals
Pursuant Private Securities Litigation Reform Act 1995 Receivables
Reconciliation Equity Regulations Limit Prices Charge Pharmaceutical Products Reduce Revenues
Related Party Transactions Relations Shareholders Other Investors
Remuneration Remuneration 2004
Remuneration 2005 Remuneration Committee
Remuneration Committee Nomination Remuneration Policy
Remuneration Policy 2005 Remuneration Structure 2004
Report 2005 Auditors Report 2007
Report 4th Key Figures Report Independent Registered Public Accounting Firm
Research Costs Preparation Start-up Expenses Research Development
Research Development Efforts Not Succeed Competitors Develop Effective Research Development Patents Licenses
Responsible Liabilities Arising Out Antitrust Litigation Responsible Liabilities Arising Out Non-compliance Laws Regulation Antitrust
Restructuring Activities Restructuring Impairment Charges
Restructuring Provisions Results Divestments
Revenue Recognition Revenue Recognition Financial Statements
Revenue Recognition Financial Statements-frequently Asked Questions Answers Revenues
Revenues 2005 Eur 1094 2004 1027 Revenues 2005 Eur 2425 2004 2344
Revenues 2006 Eur 1125 2005 1094 Revenues 2006 Eur 1129 2005 975
Revenues 2006 Eur 1959 2005 1740 Revenues 2006 Eur 2287 2005 2038
Revenues 2006 Eur 516 2005 471 Revenues 2006 Eur 523 2005 511
Revenues 2006 Eur 740 2005 703 Revenues 2006 Eur 767 2005 787
Revenues 2006 Eur 922 2005 886 Revenues 2006 Eur 966 2005 893
Revenues Autonomous Growth Revenues Cost Income
Revenues Operating Income Activities Risk Factors
Risks Production Processes Adversely Affect Results Operations Role Society
Rules Procedure Codes Conduct Complaints Procedures Safe Harbor Statement
Salaries Wages Social Charges Sales
Sales 2004 Eur 1024 2003 1010 Sales 2004 Eur 1592 2003 1489
Sales 2004 Eur 175 2003 171 Sales 2004 Eur 1911 2003 1842
Sales 2004 Eur 2010 2003 2273 Sales 2004 Eur 274 2003 267
Sales 2004 Eur 366 2003 479 Sales 2004 Eur 494 2003 492
Sales 2004 Eur 575 2003 544 Sales 2004 Eur 613 2003 604
Sales 2004 Eur 863 2003 858 Sales 2004 Eur 875 2003 832
Sales 2004 Eur 927 2003 880 Sales 2004 Eur 980 2003 1008
Sales Cost Income Sales Operating Income Activities
Salt Schedule Valuation Qualifying Accounts
Scheme Document Other Related Jurisdiction Outside Netherlands Inform Seasonality Adversely Affect Operating Results Coatings Chemicals Business
Segment Reporting Sensitivity Analysis
Separation Pharma Business Track Share Ownership
Share Profit Associates Share-based Compensation
Share-based Payments Shareholders
Shareholders Equity Shares Akzo Nobel Held Members Supervisory Board Management
Short-term Borrowings Short-term Employee Benefits
Short-term Incentive Annual Bonus Short-term Incentive Annual Bonus 2006
Signatures Significant Changes
Sources Availability Raw Materials Special Benefits
Statutory Other Reserves Statutory Reserves
Stock Options Performance-related Shares Stock-based Compensation
Strategic Decision Making Risks Strategy
Strong Cash Flow Generated Operating Activities Eur Strong Financial Position
Subscribed Share Capital Subsequent Events
Subsidiaries Associated Companies Summary Significant Accounting Policies Used Preparing Consolidated Financial
Summary Significant Differences Between Dutch Corporate Governance Practices Supervisory Board
Supervisory Board Activities Supplemental Cash Flow Disclosures
Surface Chemistry Surfactants
Table Contents Tax
Tax Rate Taxation Capital Gains
Taxation Dividends Taxes
Technology Engineering Top-line Record Net Income Eur 115
Topline Growing Operational Results Lower Trade Other Payables
Trade Other Receivables Trading Conditions
Trading Conditions 2006 Translation Foreign Currencies
Treasury Shares Unable Retain Key Personnel Attract New Adverse Effect
Understanding Whether Formal Informal Acquire Interest Relevant Securities Undertakings Implement Scheme
United States Taxation Valuation
Velperweg 6824 Arnhem Velperweg 6824 Arnhem Netherlands Address Principal Executive Offices
Voting Rights Withholding Tax
Workforce 1040 Organic Growth Acquisitions Partially Offset Divestments Workforce 1100 Organic Growth Acquisitions Partially Offset Divestments
Workforce Balance 150 Workforce Down 680 Due Restructurings
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki